From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Thu, 2 Apr 2020 10:58:08 +0000
To: Mascola, John (NIH/VRC) [E]
Subject: FW: Secretary's Medical Countermeasure Advisory Panel

As per our discussion.

From: Kadlec, Robert (OS/ASPR/IO) [OY >

Sent: Thursday, April 2, 2020 6:46 AM

To: Bright, Rick (OS/ASPR/BARDA) [___. ©) ©}; Disbrow, Gary (OS/ASPR/BARDA)
f=) J; Lambert, Linda (OS/ASPR/BARDA)

Ce: Shuy, Bryan (OS/ASPR/IO) Ff; Harrison, Brian (HHS/IOS)
CY}; Hassell, David (Chris) (OS/ASPR/IO)f— OS EY>
Subject: Secretary's Medical Countermeasure Advisory Panel

Importance: High

Rick, Ga ry and Linda:

The Secretary has directed me to establish a HHS Senior Advisory Panel of key HHS Operating
Divisions( (NIH, CDC & FDA) to include head of agencies or their designees to oversee and
provide recommendations to the Secretary concerning the development and procurement
medical countermeasures (MCM), (vaccines, therapeutics, diagnostics and devices). In meeting
this directive, | have asked Dr. Chris Hassell to organize and serve as the intermediary to
schedule and coordinate. It is the intent to hold the first virtual meeting of this panel Sunday, 4
April time TBD. The frequency of further meetings will be determined at the inaugural meeting.

The Agenda should include :

Overall COVID-19 Strategy & Plan (S min)

Activities to Date (e.g. industry outreach, RFP BAA etc.) (5 min)

High level overview of current MCM portfolio (5 min)

Detailed briefing of current vaccine technical development efforts, timeline and
costs (30 min)

e Discussion by participants (30 min)

| ask that the materials for this meeting be submitted by noon April 3 to the APSR IO to be
reviewed and be distributed to the Panel membership by noon Saturday April 4. Thank you

Bob

NIH-000082
